Founded
Address
Cross Creek Capital LP
150 Social Hall Avenue
4th Floor
Salt Lake City, UT 84111
United States
Phone
Email
Website
Recent investment activity
KANDO id: 3228
Corporate information
Registration country
Funds managed
Fund | Type | Vintage | Currency | Committed capital |
---|---|---|---|---|
Cross Creek Capital Partners II | USD | 75,000,000 |
Funding rounds
Investment preferences
Top investment portfolio themes
finance (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 48Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
BlueArc Corp | N/A | |||||
Cardica Inc | Manufacturer of vascular devices and products. | N/A | ||||
CENX Inc | The world's first and most connected Carrier Ethernet Exchange Network. | N/A | ||||
CoreValve Inc | Medical device company of transcatheter product. | N/A | ||||
CryoCor Inc | N/A | |||||
Data Sciences International Inc | Pioneer in the field of wireless monitoring since 1984 | N/A | ||||
E2open Inc | Provider of supply chain management software delivered as a service for improved visibility and control over distributed global supply networks. | N/A | ||||
FrameMax Inc | N/A | |||||
GeneOhm Sciences Inc | Rapid, low cost MRSA testing platform | N/A | ||||
Incipient Inc | Network-based storage services software company. | Series E | ||||
IntegenX Inc | Developing equipment for molecular diagnostics | Series C | ||||
LegalZoom.com Inc | N/A | |||||
Mavenir Systems Inc | Series E | |||||
Mformation Software Technologies Inc | N/A | |||||
Miramar Labs Inc | Developing devices for aesthetic indications | N/A | ||||
Netuitive Inc | Provider of real-time analysis software for business service management (BSM). | N/A | ||||
NeurogesX Inc | N/A | |||||
Neutral Tandem Inc | N/A | |||||
NxStage Medical Inc | Hemofiltration for kidney failure | N/A | ||||
Ocera Therapeutics Inc | Development of drugs to treat gastrointestinal diseases | N/A | ||||
OpGen Inc | Provider of Whole Genome Mapping technologies for high-precision microbial analysis markets. | Series C | ||||
Ophthonix Inc | N/A | |||||
Orexigen Therapeutics Inc | N/A | |||||
Orqis Medical Corp | Develops and sells minimally invasive devices for improving cardiac performance through aortic flow therapy. | N/A | ||||
Rules-Based Medicine Inc (RBM) | Leading multiplexed biomarker testing company. | N/A |